Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion
Huabo Wang(University of Pittsburgh Medical Center), Edward V. Prochownik(UPMC Hillman Cancer Center)
Cited by 42
Related Papers
Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
|Oncotarget|2015|55
Alterations in c-Myc phenotypes resulting from dynamin-related protein 1 (Drp1)-mediated mitochondrial fission
|Cell Death and Disease|2013|27
Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia
|Cellular and Molecular Gastroenterology and Hepatology|2022|22